Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NEXI-001 by NexImmune for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
NEXI-001 is under clinical development by NexImmune and currently in Phase II for Relapsed Acute Myeloid Leukemia. According to GlobalData,...
NEXI-001 by NexImmune for Refractory Acute Myeloid Leukemia: Likelihood of Approval
NEXI-001 is under clinical development by NexImmune and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData,...
NEXI-001 by NexImmune for Myelodysplastic Syndrome: Likelihood of Approval
NEXI-001 is under clinical development by NexImmune and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...